Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF
CERY
$1.19B
| $3K | ﹤0.01% |
82
-24
| -23% | -$865 |
2025 Q3
3 quarters
|
|
1452
Autoliv
ALV
$9B
| $2K | ﹤0.01% |
21
| – | – |
2024 Q3
7 quarters
|
|
1453
Octave Specialty Group
OSG
$229M
| $2K | ﹤0.01% |
325
| – | – |
2022 Q1
17 quarters
|
|
1454
Applovin
APP
$135B
| $2K | ﹤0.01% |
4
-6
| -60% | -$2.9K |
2024 Q3
7 quarters
|
|
1455
Axon Enterprise
AXON
$24.8B
| $2K | ﹤0.01% |
3
+1
| +50% | +$418 |
2026 Q1
1 quarter
|
|
1456
Best Buy
BBY
$22.3B
| $2K | ﹤0.01% |
28
-11
| -28% | -$731 |
2025 Q1
5 quarters
|
|
1457
BHP
BHP
$210B
| $2K | ﹤0.01% |
24
| – | – |
2024 Q3
7 quarters
|
|
1458
VanEck Digital Native Economy ETF
GENZ
$16M
| $2K | ﹤0.01% |
57
| – | – |
2025 Q1
5 quarters
|
|
1459
BWX Technologies
BWXT
$11.8B
| $2K | ﹤0.01% |
+8
| New | +$1.67K |
2026 Q2
0 quarters
|
|
1460
Cognex
CGNX
$8.5B
| $2K | ﹤0.01% |
+23
| New | +$1.4K |
2026 Q2
0 quarters
|
|
1461
Credo Technology Group
CRDO
$25.3B
| $2K | ﹤0.01% |
+6
| New | +$1.19K |
2026 Q2
0 quarters
|
|
1462
iShares MSCI Indonesia ETF
EIDO
$392M
| $2K | ﹤0.01% |
239
| – | – |
2024 Q3
7 quarters
|
|
1463
Fidelity Enhanced Large Cap Value ETF
FELV
$3.76B
| $2K | ﹤0.01% |
+49
| New | +$1.88K |
2026 Q2
0 quarters
|
|
1464
F&G Annuities & Life
FG
$3.35B
| $2K | ﹤0.01% |
66
| – | – |
2024 Q4
6 quarters
|
|
1465
GFL Environmental
GFL
$20.1B
| $2K | ﹤0.01% |
57
| – | – |
2023 Q4
10 quarters
|
|
1466
Grab
GRAB
$13.8B
| $2K | ﹤0.01% |
+416
| New | +$1.52K |
2026 Q2
0 quarters
|
|
1467
HDFC Bank
HDB
$133B
| $2K | ﹤0.01% |
94
| – | – |
2024 Q3
7 quarters
|
|
1468
Haleon
HLN
$39.3B
| $2K | ﹤0.01% |
253
+4
| +2% | +$37 |
2023 Q4
10 quarters
|
|
1469
Harley-Davidson
HOG
$3.46B
| $2K | ﹤0.01% |
101
-1,484
| -94% | -$35.7K |
2021 Q1
21 quarters
|
|
1470
Liberty Live Group Series A
LLYVA
$9.33B
| $2K | ﹤0.01% |
24
| – | – |
2023 Q3
11 quarters
|
|
1471
MaxCyte
MXCT
$134M
| $2K | ﹤0.01% |
1,266
| – | – |
2022 Q3
15 quarters
|
|
1472
Nova
NVMI
$10.6B
| $2K | ﹤0.01% |
3
-9
| -75% | -$4.63K |
2024 Q3
7 quarters
|
|
1473
Organon & Co
OGN
$3.64B
| $2K | ﹤0.01% |
170
| – | – |
2025 Q2
4 quarters
|
|
1474
Option Care Health
OPCH
$4.75B
| $2K | ﹤0.01% |
97
-30
| -24% | -$698 |
2024 Q3
7 quarters
|
|
1475
PG&E
PCG
$28.9B
| $2K | ﹤0.01% |
94
| – | – |
2021 Q1
21 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.